ICON’s Flex Advantage IRT Platform
Flex Advantage offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
ICON has announced Flex Advantage, its next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
Flex Advantage features:
- Randomization engine that can be adjusted mid-study or dynamically
- Plug-and-play modules for easier configuration
- Emergency unblinding support
- Enhanced reporting with customizable dashboard
- Integration with ICON products, such as ADDPLAN, Firecrest and ICONIK as well as external EDC, drug distributor and drug supply forecasting systems
Read the full release.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
